Comparative Claims In Product Promotions: FDA Isn’t Entirely Leaving It To Firms To ‘Duke It Out’

Drug comparison
US FDA is looking at drug promotions with comparative claims • Source: Shutterstock

More from Marketing & Advertising

More from Compliance